The above finding was consistent with previously reported results regarding the differential expression of CHD5 in different cancers, including neuroblastoma, melanoma, hepatocellular carcinoma, non-small cell lung cancer, and head and neck squamous cell carcinoma [20,21,22,23,24]. This evidence concerns the gene CHD5 and neuroblastoma.